Valtinson Bruner Financial Planning LLC Sells 76 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Valtinson Bruner Financial Planning LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,025 shares of the healthcare conglomerate’s stock after selling 76 shares during the quarter. Valtinson Bruner Financial Planning LLC’s holdings in UnitedHealth Group were worth $1,066,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $26,000. CGC Financial Services LLC boosted its position in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. NewSquare Capital LLC boosted its position in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares in the last quarter. LFA Lugano Financial Advisors SA boosted its position in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares in the last quarter. Finally, Annapolis Financial Services LLC boosted its position in shares of UnitedHealth Group by 38.6% during the 3rd quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock worth $40,000 after acquiring an additional 22 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded up $0.86 during trading on Thursday, reaching $504.07. The company had a trading volume of 134,903 shares, compared to its average volume of 4,316,083. The company has a fifty day moving average of $481.45 and a two-hundred day moving average of $511.98. The stock has a market capitalization of $463.78 billion, a P/E ratio of 30.76, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.26 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.49%. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on UNH. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 10th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Oppenheimer reissued an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.